Amani Fawzi, MD
Ophthalmology
Highlights
Age Groups Seen
- Adult
Languages
- Arabic
- German
- Spanish
- English
Gender
FemaleAbout
Biography
Dr. Fawzi is a vitreoretinal surgeon and clinician-scientist, the Director of Ocular Research in Oculomics at the Cole Eye Institute, Cleveland Clinic. Dr. Fawzi’s clinical expertise spans complex diabetic surgeries, macular degeneration and advanced technology in retinal imaging. Her research expertise spans the fields of human retinal imaging, mouse models of retinal disease, multi-omics and diabetic retinopathy. She is an Editorial Board Member of IOVS, a Gold Fellow and Retina Trustee of ARVO and President of the International Ocular Circulation Society. She has authored over 200 peer reviewed articles, is a frequent invited speaker at National and International meetings, and her research is funded by the NIH and the industry.
Recognized for her imaging research, Dr. Fawzi is an elected member of the American Society of Clinical Investigations and has received many honors and award including the Honor Award of the American Society of Retina Specialists, the Young Investigator Award and W. Richard Green Award of the Macula Society, the Secretariat, and Senior Achievement Awards of the American Academy of Ophthalmology.
Education & Board Certifications
Education
- Fellowship: University of California Doheny Eye Institute, 2006
- Residency: UCLA David Geffen School of Medicine, 2004
- Internship: UCLA David Geffen School of Medicine, 2001
- Graduate School: cairo university medical school, 2000
- Graduate School: cairo university medical school, 1997
- Residency: Cairo University, 1997
- Medical Education: University of Cairo Faculty of Medicine, 1992
Board Certifications
- Ophthalmology: American Board of Ophthalmology, 2006
Professional Highlights
- Cyrus Tang and Lee Professor of Ophthalmology
- Tenured Professor of Ophthalmology at Northwestern University Feinberg School of Medicine
- Internationally recognized retina specialist and clinician-scientist specializing in medical and surgical retina
- Board-certified by the American Board of Ophthalmology
- Fluent in Spanish, German, and Arabic
- Has served as editor and editorial board member for several leading ophthalmology journals, including Retina, Investigative Ophthalmology & Visual Science, and Scientific Reports
- Principal Investigator on numerous NIH-funded research grants focused on retinal imaging, diabetic retinopathy, and retinal vascular disease
Awards
- W. Richard Green Lecture and Award, Macula Society (2026)
- Elected to the American Society for Clinical Investigation (2024)
- Senior Achievement Award, American Academy of Ophthalmology (2023)
- Gold Fellow, Association for Research in Vision and Ophthalmology (2022)
- Retina Hall of Fame (2021–2022)
- Young Investigator Award, Macula Society (2020)
- Honor Award, American Society of Retina Specialists (2016)
- American Academy of Ophthalmology Achievement Award (2014)
- Best Doctors in America (2013–present)
- Top Doctors in Chicago (2012)
Professional Memberships
- American Academy of Ophthalmology
- Association for Research in Vision and Ophthalmology (ARVO)
- American Society of Retina Specialists
- American Ophthalmological Society
- Retina Society
- Macula Society
- Women in Ophthalmology
- Chicago Ophthalmological Society
- Illinois Society of Eye Physicians and Surgeons
- International Ocular Circulation Society (Founding Executive Board Member)
- International Retinal Imaging Society (Executive Board Member)
Innovations & Patents
- Leader in the development and clinical application of advanced retinal imaging technologies, including optical coherence tomography angiography (OCTA), adaptive optics imaging, and other novel imaging approaches for diagnosing and monitoring retinal diseases.
- Principal investigator on multiple NIH-funded projects developing innovative retinal imaging biomarkers for diabetic retinopathy and systemic vascular disease.
Research & Publications
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2026-07-06, Dr. Fawzi has reported the financial relationships with the companies listed below.
Donation of Financial Interest. Dr. Fawzi has consulted for, received compensation for serving as a fiduciary from, or received royalties from the following companies but instructed them to donate all compensation to not-for-profit causes or to the Cleveland Clinic to support research and education:
- Genentech, Inc
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.